I would be very interested to hear your analysis of the result. It looked about as expected to me with revenue tracking closely from the first half, but perhaps r&d came in a little higher. I assume your implication of squirrelling away profits would be around r&d spending and d&a accounting practices. Behring is an absolute beast, as expected and vifor is looking like a lousy acquisition, as expected.
Thanks for your analysis this reporting season.
I would be very interested to hear your analysis of the result....
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.16 |
Change
-0.770(0.25%) |
Mkt cap ! $148.4B | |||
| Open | High | Low | Value | Volume |
| $309.31 | $309.89 | $305.94 | $474.0M | 1.557M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $307.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.30 | 1568 | 3 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |